United States · FDA National Drug Code directory
Humira
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83457-124_5fe81b1a-cc31-444e-a0f1-1ea4f7334b89
- Product NDC
- 83457-124
- Form
- KIT
- Composition / generic term
- Adalimumab
- Labeler
- Cordavis Limited
- Marketing category
- BLA
- Marketing start / end (source format)
- 20240214
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 2 KIT in 1 CARTON (83457-124-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (83457-123-01) / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET (83457-927-01) · 83457-124-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →